The dorsal raphe nucleus (DRN) serotonergic (5-HT) system has been implicated in regulating sleep and motor control; however, its specific role remains controversial. In this study, we found that ...
Issued claims further strengthen global intellectual property portfolio supporting immune cell modulation platform and expand strategic presence in a high-growth international market LA JOLLA, CA, ...
In this article, we will look at oversold names that offer double-digit ROE growth for investors across sectors. On April 3, ...
In an interview with Hindustan Times, Edin Rose talks about her recent release, Vignesh Shivan's Love Insurance Kompany, ...
As a wave of plans for low Earth orbit (LEO) broadband constellations enters the market, a 63-year-old former NASA Branch Chief and Google executive is betting on narrow beams, higher frequencies and ...
Riccardo Balestri, MD, PhD, discusses his research on coexistent psoriasis and atopic dermatitis, also known as PsoDermatitis ...
Former Chief Sustainability Officer at Kenvue, and adjunct professor, tells Beauty Packaging what factors are advancing the ...
In a recent study published in Nature Communications, researchers created a memristor that uses a built-in oxygen gradient to ...
Get More information on Jubin Nautiyal including breaking news and opinion. Check News articles, photos, videos of Jubin ...
ARDS / hypoxemic pneumonia Phase 2 trial initiation 1H 2026; early data by year end; market opportunity of ~200,000–300,000 ...
Corcept Therapeutics(NASDAQ: CORT) took its investors for quite a ride on Hump Day. The commercial-stage biotech earned its latest nod from a regulator that afternoon and, not surprisingly, its shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results